First human trials of drug to prevent death due to severe blood loss

Researchers will launch the first Phase 1 human trials of a drug -- derived from the female hormone estrogen -- that may help patients with severe bleeding survive long enough to get to appropriate medical care. The drug may have a profound effect on an individual's ability to survive major blood loss.